NO963213L - Endotelinreseptorantagonister - Google Patents

Endotelinreseptorantagonister

Info

Publication number
NO963213L
NO963213L NO963213A NO963213A NO963213L NO 963213 L NO963213 L NO 963213L NO 963213 A NO963213 A NO 963213A NO 963213 A NO963213 A NO 963213A NO 963213 L NO963213 L NO 963213L
Authority
NO
Norway
Prior art keywords
unsubstituted
coor6
hal
independently
group
Prior art date
Application number
NO963213A
Other languages
English (en)
Other versions
NO963213D0 (no
Inventor
Werner Mederski
Mathias Osswald
Dieter Dorsch
Claudia Wilm
Claus J Schmitges
Maria Christadler
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO963213D0 publication Critical patent/NO963213D0/no
Publication of NO963213L publication Critical patent/NO963213L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Quinoline Compounds (AREA)

Abstract

Nye forbindelser med formel I hvor -Y-Z- er -NR7-CO-, -N=C(OR7)- eller -N=CR8-; R1 er Ar; R2 er COOR6, (CH2)nCOOR6, CN, lH-tetrazol-5-yl eller CONHS02Ar; R3, R4 og R5 er uavhengig av hverandre R6, OR6, S(O),,R6, Hal, N02, NR6R6', NHCOR6, NHSO2R6, OCOR6, COR6, COOR6 eller CN, idet R3 og R4 til sammen også kan utgjøre en O(CH2)nO-gruppe; R6 og R6' er uavhengig av hverandre H, alkyl med 1-6 C-atomer, benzyl eller fenyl; R7 er (CH2)nAr; R8 er Ar eller OAr; Ar er usubstituert eller en, to eller tre ganger med R9, R10 eller R11 substituert fenyl, eller usubstituert naftyl eller en usubstituert eller i fenyldelen en eller to ganger med R9 eller R10 substituert D-gruppe eller en usubstituert eller i sykloheksadien- yldelen en eller to ganger med R9 eller substituert N X-gruppe, R9, R10 og R11 er uavhengig av hverandre R6, OR6, Hal, CF3, OCF3, OCHF2, OCH2F, N02, NR6R6', NHCOR6, CN, NHS02R6, COOR6, COR6, CONHS02Ar, O(CH2)nR2, 0(CH2)nOR6 eller S(0)nR6; E er CH2, S eller O; D er karbonyl eller [C(R6R6')]n; X er O eller S; Hal er F, Cl, Br eller I; m er O, l eller 2; og n er l, 2 eller 3; samt deres salter, utviser endotelin- reseptorantagonistiske egenskaper .
NO963213A 1995-08-02 1996-08-01 Endotelinreseptorantagonister NO963213L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19528418A DE19528418A1 (de) 1995-08-02 1995-08-02 Endothelin-Rezeptor-Antagonisten

Publications (2)

Publication Number Publication Date
NO963213D0 NO963213D0 (no) 1996-08-01
NO963213L true NO963213L (no) 1997-02-03

Family

ID=7768528

Family Applications (1)

Application Number Title Priority Date Filing Date
NO963213A NO963213L (no) 1995-08-02 1996-08-01 Endotelinreseptorantagonister

Country Status (16)

Country Link
US (1) US5731321A (no)
EP (1) EP0757039A1 (no)
JP (1) JPH0940649A (no)
KR (1) KR970010746A (no)
AR (1) AR004675A1 (no)
AU (1) AU705959B2 (no)
BR (1) BR9603252A (no)
CA (1) CA2182469A1 (no)
CZ (1) CZ224096A3 (no)
DE (1) DE19528418A1 (no)
HU (1) HUP9602127A1 (no)
MX (1) MX9603199A (no)
NO (1) NO963213L (no)
PL (1) PL315479A1 (no)
SK (1) SK100296A3 (no)
ZA (1) ZA966552B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6251861B1 (en) * 1996-06-27 2001-06-26 Takeda Chemical Industries, Ltd. Treatment of cerebral infarction using cyclic hexapeptides
DE19839499A1 (de) * 1998-08-29 2000-03-02 Merck Patent Gmbh 2-Oxo-2H-chinolinderivate
DE10155076A1 (de) * 2001-11-09 2003-05-22 Merck Patent Gmbh Verwendung von Endothelin-Rezeptor-Antagonisten zur Behandlung von Tumorerkrankungen
US7825131B2 (en) * 2003-09-23 2010-11-02 Merck Sharp & Dohme Corp. Quinoline potassium channel inhibitors
US7939545B2 (en) * 2006-05-16 2011-05-10 Boehringer Ingelheim International Gmbh Inhibitors of human immunodeficiency virus replication
US8377949B2 (en) * 2007-08-16 2013-02-19 Boehringer Ingelheim International Gmbh Quinazolinedione chymase inhibitors
EP2220076B1 (en) * 2007-11-15 2012-01-18 Boehringer Ingelheim International GmbH Inhibitors of human immunodeficiency virus replication
EP2220046B1 (en) 2007-11-16 2014-06-18 Gilead Sciences, Inc. Inhibitors of human immunodeficiency virus replication

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1336714C (en) * 1987-08-20 1995-08-15 Yoshihiro Fujikawa Quinoline type mevalonolactone inhibitors of cholesterol biosynthesis
US5514691A (en) * 1993-05-20 1996-05-07 Immunopharmaceutics, Inc. N-(4-halo-isoxazolyl)-sulfonamides and derivatives thereof that modulate the activity of endothelin
RU2086544C1 (ru) * 1991-06-13 1997-08-10 Хоффманн-Ля Рош АГ Бензолсульфонамидные производные пиримидина или их соли, фармацевтическая композиция для лечения заболеваний, связанных с активностью эндотелина
GB9115153D0 (en) * 1991-07-12 1991-08-28 Patel Bipin C M Sol-gel composition for producing glassy coatings
DE4208304A1 (de) * 1992-03-16 1993-09-23 Merck Patent Gmbh 2-oxochinolinderivate
US5565472A (en) * 1992-12-21 1996-10-15 Pfizer Inc. 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents
ZA939516B (en) * 1992-12-22 1994-06-06 Smithkline Beecham Corp Endothelin receptor antagonists
DE69422742T2 (de) * 1993-03-19 2000-08-17 Merck & Co Inc Phenoxyphenylessigsäurederivate
JPH06340658A (ja) * 1993-04-08 1994-12-13 Kyowa Hakko Kogyo Co Ltd ベンゾイミダゾール誘導体
US5817653A (en) * 1993-08-06 1998-10-06 Smithkline Beecham Corporation Endothelin receptor antagonists
DE4341663A1 (de) * 1993-12-07 1995-06-08 Basf Ag Anellierte 2-Oxopiperazine, ihre Herstellung und Verwendung

Also Published As

Publication number Publication date
MX9603199A (es) 1997-07-31
PL315479A1 (en) 1997-02-03
SK100296A3 (en) 1997-03-05
ZA966552B (en) 1997-02-18
HUP9602127A1 (hu) 1998-05-28
HU9602127D0 (en) 1996-09-30
AU705959B2 (en) 1999-06-03
BR9603252A (pt) 1998-04-28
US5731321A (en) 1998-03-24
KR970010746A (ko) 1997-03-27
CZ224096A3 (en) 1997-02-12
DE19528418A1 (de) 1997-02-06
AU6079296A (en) 1997-02-06
JPH0940649A (ja) 1997-02-10
CA2182469A1 (en) 1997-02-03
NO963213D0 (no) 1996-08-01
AR004675A1 (es) 1999-03-10
EP0757039A1 (de) 1997-02-05

Similar Documents

Publication Publication Date Title
HRP20020175B1 (en) N-heterocyclikc derivatives as nos inhibitors
HUP0400570A2 (hu) Feniletenil- vagy feniletinil-heteroaril-származékok mint glutamát receptor antagonisták, alkalmazásuk, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
DK0862567T3 (da) 5-azabicyclo[3.1.0]hexylalkyl-2-piperidoner og-glutarimider som neurokininreceptorantagonister
ATE282614T1 (de) Phenylharnstoff und phenylthioharnstoffderivate
DE69330351D1 (de) 5-arylindol-derivate und ihre verwendung als serotonin (5-ht1)-agonisten
NO912739D0 (no) Nye 3-arylindol- og 3-arylindazolderivater.
DE59610527D1 (de) S-Triazinederivate als Lichtschutzmittel für Kosmetika
YU59601A (sh) Derivati piridopiranoazepina, njihovo pripremanje i terapeutska primena
NO963213L (no) Endotelinreseptorantagonister
ATE182889T1 (de) Bicyclische amidinderivate als no-synthetase inhibitoren
ATE374748T1 (de) Phenylcyclohexylpropanolaminderivate, deren herstellung und therapeutsche anwendung
ATE137759T1 (de) S'-adenosyl-methionin-decarboxylase-inhibitoren
ES2099180T3 (es) Derivados del benzopirano y procedimientos para su preparacion.
MEP12408A (en) Acyloxypyrrolidine derivatives and use thereof as ligands of v1b or both v1b and v1a receptors
DE60204668D1 (de) Piperazinderivate und deren verwendung als 5-ht1b liganden
FI955680A (fi) Psoraleenijohdannaiset, niiden valmistus ja käyttö
ES2154191A1 (es) Nuevos acetales derivados de los 2-alquil-5-halo-3-(2'-(tetrazol-5-il)-bifenil-4-ilmetil)-3h-imidazol-4-carbaldehidos.
TH34361A (th) สารประกอบ
MX9804482A (es) Quinolinas y quinazolinas utiles en terapias.
AR003970A1 (es) Nuevos compuestos antagonistas de receptores de endotelina, procedimiento para prepararlos, composiciones farmaceuticas que los contienen y procedimientopara preparar estas composiciones farmaceuticas.